Page last updated: 2024-11-06

fast blue bb

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Fast Blue BB: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID67108
SCHEMBL ID301964
MeSH IDM0066421

Synonyms (66)

Synonym
4-benzoylamino-2,5-diethoxyaniline
spectrolene blue bb
daito blue base bb
nsc-37184
tulabase fast blue bb
c.i. azoic diazo component 20, base
blue salt nbb
blue 2b base
2-amino-5-benzoylaminohydroquinone diethyl ether
fast blue bbn
diazo fast blue bb
120-00-3
nsc37184
amarthol fast blue bb base
azoic diazo component 20, base
fast blue bb base
stabamine blue bb
naphtoelan blue bb base
2,5-diethoxy-4-benzamidoaniline
hiltonil fast blue bb base
c.i. 37175
fast blue eb base
brentamine fast blue 2b base
azoene fast blue bb base
brentamine fast blue bb base
fast blue base bb
c.i. azoic diazo component 20
sanyo fast blue bb base
OPREA1_096764
n-(4-amino-2,5-diethoxyphenyl)benzamide
fast blue bb
azoic diazo component 20 (base)
4'-amino-2',5'-diethoxybenzanilide
cnxzlzneiyfzgu-uhfffaoysa-
inchi=1/c17h20n2o3/c1-3-21-15-11-14(16(22-4-2)10-13(15)18)19-17(20)12-8-6-5-7-9-12/h5-11h,3-4,18h2,1-2h3,(h,19,20)
AKOS000120746
STK761212
nsc 37184
benzamide, n-(4-amino-2,5-diethoxyphenyl)-
benzanilide, 4'-amino-2',5'-diethoxy-
einecs 204-363-8
9fb70c7gdi ,
unii-9fb70c7gdi
ec 204-363-8
FT-0631686
azoic diazo no. 20
4-benzamido-2,5-diethoxyaniline
ci 37175
SCHEMBL301964
DTXSID8059504
n-(4-amino-2,5-diethoxyphenyl)benzamide #
CNXZLZNEIYFZGU-UHFFFAOYSA-N
fast blue bb (c.i. 37175)
mfcd00009091
sr-01000526358
J-004229
n-(4-amino-2,5-diethoxyphenyl)benzamide, dye content 90 %
SR-01000526358-1
CS-0196559
Z104484924
4-benzamido-2, 5-diethoxyaniline
AMY40949
Q27272487
D88494
4-amino-1-(benzoylamino)-3,6-diethoxybenzene
A920128

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" Regarding the treatments, the group that received AQB showed to have increased polyphenolic bioavailability in brainstem (p<0."( [Analysis of tissue bioavailability of total polyphenols by Folin Ciocalteu and Fast Blue BB techniques in organs of BALB/C/c mice].
Albrecht, C; Miranda, AR; Soria, EA, 2017
)
0.68
"FBBB method showed higher estimations of polyphenolic bioavailability than FC, and this could be related to higher specificity of the technique to react with phenolic compounds."( [Analysis of tissue bioavailability of total polyphenols by Folin Ciocalteu and Fast Blue BB techniques in organs of BALB/C/c mice].
Albrecht, C; Miranda, AR; Soria, EA, 2017
)
0.68
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (35.29)18.7374
1990's4 (23.53)18.2507
2000's1 (5.88)29.6817
2010's4 (23.53)24.3611
2020's2 (11.76)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 35.40

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index35.40 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index5.15 (4.65)
Search Engine Demand Index36.43 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (35.40)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other18 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]